Edexcel A-Level Biology: Immunity, Infection and Forensics — Complete Revision Guide (9BI0)

Immunity, Infection and Forensics is one of the most clinically resonant topics on Edexcel A-Level Biology B (9BI0) — and after COVID-19 it has become one of the most current. Once you can classify pathogens by structure and lifecycle, distinguish innate from adaptive immunity, explain antibody mechanism and class switching, and reason about herd immunity thresholds and antimicrobial resistance, you have the framework for every "how does the body respond to X infection" question on Paper 1 and the synoptic gene-technology questions on Paper 3.

This guide is a topic-by-topic walkthrough of the immunity and infection content. It covers the four major pathogen classes (bacteria, viruses, fungi, protoctista), bacterial growth dynamics and aseptic culture technique, pathogen transmission and epidemiology, plant defences against pathogens, the non-specific (innate) immune response, the specific (adaptive) immune response with B and T cells, antibody structure and mechanism, vaccination and herd immunity, and the antimicrobial resistance crisis. For each topic you will find the core ideas, common pitfalls, a worked example, and a link into the LearningBro Immunity, Infection and Forensics course.

What the Edexcel 9BI0 Specification Covers

Edexcel A-Level Biology B (9BI0) is examined in three written papers. Topic 6 — Immunity, Infection and Forensics — sits in the first half of the specification and is examined directly on Paper 1, with synoptic questions on Paper 3 frequently returning to antibody structure, vaccine design, and AMR mechanisms.

Microbiology questions tend to fall into three styles: short recall on pathogen structures or immune-cell types; mechanism questions on antibody mode of action or vaccine immunology; and extended-response questions integrating innate plus adaptive responses, or comparing transmission strategies across organisms. The table below maps the main sub-topics to a typical paper weighting.

Sub-topic	Spec area	Typical paper weight
Pathogen classes	Topic 6	3–5 marks
Bacterial growth and aseptic technique	Topic 6	4–6 marks
Disease transmission	Topic 6	4–6 marks
Plant defences	Topic 6	3–5 marks
Non-specific immunity	Topic 6	4–6 marks
Specific immunity (B and T cells)	Topic 6	6–10 marks
Antibodies and immune memory	Topic 6	6–8 marks
Vaccination and herd immunity	Topic 6	4–6 marks
Antibiotics and AMR	Topic 6	4–6 marks

These weights are estimates. What is reliable is that an antibody-mechanism or specific-immunity question and an AMR or vaccine-strategy question appear on most papers.

Pathogen Classes

Pathogens fall into four major structural classes, each with distinct biology and therapeutic targets.

Bacteria are prokaryotic — peptidoglycan cell wall, 70S ribosomes, circular DNA in nucleoid, no membrane-bound organelles, divide by binary fission. Pathogenic examples: Mycobacterium tuberculosis, Streptococcus pneumoniae, Salmonella. The 70S ribosome is the target of selective antibiotics like streptomycin and tetracyclines.

Viruses are acellular — protein capsid (sometimes with lipid envelope) packaging DNA or RNA, with no metabolism. Obligate intracellular parasites. Lytic cycle (rapid replication, host cell bursts) or lysogenic cycle (genome integrates as prophage, replicates with host until induced). Examples: influenza, HIV, SARS-CoV-2, herpes simplex.

Fungi are eukaryotic — chitin cell wall, 80S ribosomes, mostly multicellular hyphal networks (with single-celled exceptions like Saccharomyces). Pathogenic examples: Candida albicans, dermatophytes (ringworm), Aspergillus. Antifungal drugs target fungal-specific structures (ergosterol synthesis, chitin synthesis).

Protoctista (Protista) are eukaryotic, varied. The most clinically significant: Plasmodium (malaria, lifecycle alternating between Anopheles mosquito and human host), Trypanosoma brucei (African sleeping sickness), Entamoeba histolytica (amoebic dysentery).

Worked example. Explain why penicillin can be administered safely to humans at therapeutic doses while killing many bacterial pathogens. Penicillin inhibits bacterial transpeptidase enzymes that crosslink peptidoglycan in the bacterial cell wall. Humans have no peptidoglycan — there is no human equivalent enzyme. The drug is therefore highly selectively toxic for bacteria. Selective toxicity is the central design principle of all antibiotics — exploit a pathogen-specific structure or pathway absent in the host.

A common pitfall is to call all microorganisms "bacteria" generically. Another is to think viruses are alive in the simple sense — they reproduce and evolve but lack metabolism, growth and homeostasis. A third is to confuse the 70S/80S ribosome distinction (70S = prokaryotic, mitochondrial, chloroplast; 80S = eukaryotic cytoplasmic) — the basis of much selective antibiotic toxicity.

See the pathogen classes lesson for structural comparisons.

Bacterial Growth and Aseptic Technique

Under controlled conditions, a bacterial population follows a predictable growth curve: lag phase (no division yet — cells adapt, induce enzymes, repair inoculation damage); log/exponential phase (division at maximum rate, linear in log space); stationary phase (birth = death — substrate exhausted, waste accumulated, quorum sensing); death phase (cells lyse). On log axes, exponential phase appears linear.

Viable count uses serial dilutions and CFU (colony-forming units) to count only living, dividing cells. Total count uses haemocytometers to count all cells (alive and dead). The two diverge after the stationary phase.

Aseptic technique prevents contamination during culture. Key principles: flame-sterilise the inoculation loop until red hot; cool briefly in air; work near a Bunsen flame to create an updraft; flame the neck of a culture bottle before re-stoppering; lift agar-plate lids at minimum angle; incubate plates inverted (gravity prevents condensation drops disrupting colonies); always include controls — sterile-medium plate (proves the medium itself was sterile), no-inoculum plate (proves contamination didn't enter via the workflow).

Worked example. A 10⁻⁶ dilution from an original culture gives 47 colonies on a 1 mL plate. Calculate the original concentration in CFU/mL. CFU = (count × dilution factor⁻¹) / volume = (47 × 10⁶) / 1 mL = 4.7 × 10⁷ CFU/mL. The 30–300 CFU rule: counts outside this range are statistically unreliable — too few risks Poisson noise; too many causes overlap and undercounting.

A common pitfall is to confuse viable with total count. Another is to forget the controls — without them, a contaminated plate is indistinguishable from a successful inoculation. A third is thinking aseptic = sterile (aseptic = preventing contamination via technique; sterile = absence of all microorganisms).

See the bacterial growth and aseptic technique lessons for protocol diagrams and growth-curve graphs.

Disease Transmission

Pathogens spread between hosts via several routes. Direct contact (touch, sex — HIV, herpes); droplet (sneezing, coughing — influenza, TB, COVID); vector-borne (an intermediate organism carries pathogen between hosts — Anopheles for malaria, ticks for Lyme); food/water-borne (faecal-oral — cholera, hepatitis A, Salmonella); vertical (mother to child during pregnancy, birth, or breastfeeding — HIV, hepatitis B, group B Streptococcus); fomite (contaminated surfaces — norovirus, MRSA in hospitals).

R₀ (basic reproduction number) is the average number of secondary infections produced by one infected individual in a fully susceptible population. R₀ > 1 → epidemic spread; R₀ < 1 → outbreak dies out. The herd-immunity threshold proportion of immune individuals needed to halt transmission is 1 − 1/R₀ — for measles (R₀ ≈ 12–18), threshold ≈ 92–95%; for SARS-CoV-2 ancestral strain (R₀ ≈ 2.5), threshold ≈ 60%.

Worked example. Plasmodium falciparum malaria has R₀ ranging from 1 to >1000 depending on local mosquito ecology. Predict why simple case isolation fails to control malaria. Case isolation works for direct or droplet transmission (TB, COVID) where the pathogen passes person-to-person. Malaria is vector-borne — the Anopheles mosquito is the bridge — so isolating an infected human stops human-to-mosquito transmission only if the human is also screened from mosquitoes. Mosquito-control measures (bed nets, indoor residual spraying, larval source management) and human prophylaxis (artemisinin combination therapy) are needed jointly.

A common pitfall is to confuse pathogen with disease. Another is to miss the difference between vector (organism transmitting pathogen, e.g. Anopheles) and reservoir (organism harbouring pathogen long-term — fruit bats for Ebola).

See the disease transmission lesson for transmission-route diagrams.

Plant Defences

Plants have a sophisticated two-tier immune system. Innate (constitutive) defences: waxy cuticle, lignified cell walls, antimicrobial proteins (defensins) constitutively present. Induced defences: triggered on pathogen recognition.

The hypersensitive response is the plant analogue of programmed cell death: pathogen effectors recognised by intracellular NLR (R-protein) receptors → ROS burst → callose deposition at plasmodesmata blocks pathogen spread → programmed cell death isolates the pathogen → salicylic acid signalling triggers systemic acquired resistance (SAR) in distal tissue. The host sacrifices a few cells to save the whole plant.

Worked example. Predict the consequence of a mutation that knocks out salicylic acid signalling. The local hypersensitive response would still occur (recognition and PCD are downstream of NLR signalling), but systemic acquired resistance would fail — distal leaves would not be primed for fast secondary response. The plant would be more vulnerable to a second wave of infection at distant sites.

A common pitfall is to think plants have no immune system — they have a sophisticated PAMP-triggered + effector-triggered system with parallels to animal innate immunity.

See the plant defences lesson for hypersensitive-response diagrams.

The Non-Specific Immune Response

Non-specific (innate) immunity is immediate, pre-existing, and recognises pathogen classes rather than individual antigens. First-line defences: skin, mucous membranes, lysozyme, gastric acid. Second-line: phagocytes, complement, interferons.

Phagocytosis in detail: pathogen-associated molecular patterns (PAMPs) recognised by pattern-recognition receptors (PRRs, e.g. Toll-like receptors) on macrophages → cytokine release → neutrophil recruitment via chemotaxis → opsonisation by C3b and antibodies enhances binding → engulfment → phagosome → fusion with lysosome → digestion by hydrolytic enzymes + ROS burst (NADPH oxidase) + acidic pH → fragments presented on MHC class II for adaptive-immunity priming.

Complement is a soluble cascade with three activation pathways (classical, alternative, lectin) converging on C3b deposition (opsonisation) and the membrane attack complex (lyses bacteria via membrane perforation).

Worked example. Explain why patients with chronic granulomatous disease (CGD — defective NADPH oxidase) suffer recurrent infections. NADPH oxidase generates the ROS burst within phagolysosomes; without it, engulfed pathogens are not killed efficiently — particularly catalase-positive organisms like Staphylococcus aureus and Aspergillus that detoxify the reduced ROS produced. Patients require lifelong prophylactic antibiotics; gene therapy and bone-marrow transplant are curative options.

A common pitfall is to treat non-specific immunity as unsophisticated — PRRs are highly evolved and specific to pathogen classes. Another is to forget complement as the third arm.

See the non-specific immunity lesson for phagocytosis diagrams.

The Specific Immune Response: B Cells and T Cells

Adaptive (specific) immunity is antigen-specific, develops over days, and produces immunological memory. Two arms: humoral (antibody-mediated, B cells) and cell-mediated (T cells).

Antigen presentation primes adaptive responses: APCs (dendritic cells, macrophages, B cells) engulf pathogens, load peptide fragments onto MHC class II, display the MHC II–peptide complex on their surface, and migrate to lymph nodes to encounter T cells.

CD4⁺ T-helper cells recognise MHC II–peptide via their TCR. Activation requires both TCR engagement and co-stimulation (CD28–B7) — the two-signal rule prevents accidental activation against self. Activated T-helpers secrete cytokines (IL-2, IL-4) that drive B-cell proliferation and differentiation.

B cells with matching surface antibody receptor proliferate clonally → some differentiate into plasma cells (antibody factories), some into memory B cells.

CD8⁺ cytotoxic T cells recognise MHC class I–peptide on infected cells (every nucleated cell expresses MHC I, displaying samples of internal proteins for surveillance). Activated CD8⁺ cells release perforin and granzymes → induce apoptosis in the infected cell.

Worked example. HIV destroys CD4⁺ T-helper cells. Predict the consequence for both arms of adaptive immunity. Without T-helper cytokines, B cells cannot mount a strong antibody response, class switching from IgM → IgG fails, and CD8⁺ T-cell activation is impaired. Both humoral and cell-mediated immunity collapse, leaving the patient vulnerable to opportunistic infections (Pneumocystis pneumonia, candidiasis, Kaposi's sarcoma) and the syndrome AIDS.

A common pitfall is to confuse CD4⁺ T-helper (recognises MHC II, secretes cytokines) with CD8⁺ cytotoxic (recognises MHC I, kills infected cells). Another is to miss the two-signal rule.

See the specific immunity lesson for activation-cascade diagrams.

Antibodies and Immune Memory

Antibodies (immunoglobulins) are Y-shaped proteins composed of two heavy and two light chains held by disulfide bonds. The variable Fab regions at the tip of each arm bind antigen with high specificity; the constant Fc region at the base mediates effector functions.

Five immunoglobulin classes: IgM (early response, pentameric, low affinity, complement-fixing); IgG (mature response, monomeric, high affinity, crosses placenta); IgA (mucosal, dimeric, in tears, saliva, breastmilk); IgE (allergy and parasite responses, binds mast cell Fc receptors); IgD (B-cell receptor function, role poorly characterised).

Class switching from IgM → IgG → IgA → IgE is driven by T-helper cytokines (IL-4 → IgG, IL-5 → IgA, IL-4 + IL-13 → IgE) and involves DNA recombination at the constant-region locus, preserving the V-region antigen specificity.

Antibody mechanisms: opsonisation (Fc tag for phagocyte uptake); agglutination (cross-linking pathogens for slower clearance); complement activation (classical pathway → MAC); neutralisation (blocking pathogen entry or toxin function).

Primary vs secondary response: primary is slow (~7-day lag, IgM-dominated, modest peak); secondary is rapid (~1–2-day lag, IgG-dominated, much higher peak) due to memory cells.

Worked example. Predict the antibody response to a second exposure to the same pathogen 5 years later, and explain. Memory B cells (with high-affinity BCRs from somatic hypermutation in the original response) rapidly differentiate into plasma cells; IgG titre rises within 1–2 days to a peak much higher than the primary response. This is the substrate of vaccination and durable immunity.

A common pitfall is to think antibodies kill bacteria directly — most action is via opsonisation, agglutination, complement, and neutralisation. Another is to confuse the immunoglobulin classes.

See the antibodies lesson for Y-structure diagrams and primary/secondary response curves.

Vaccination and Herd Immunity

Vaccines present antigens without active pathogen, eliciting protective antibodies and memory cells via the same cascade as a real infection. Five major vaccine types: live attenuated (e.g. MMR, BCG — strong, durable; contraindicated in immunocompromised); inactivated/killed (e.g. polio IPV — safe but weaker, needs adjuvant); subunit (e.g. hepatitis B — purified antigen); toxoid (e.g. tetanus, diphtheria — inactivated toxin); mRNA (e.g. Pfizer-BioNTech / Moderna for COVID — encodes antigen via lipid nanoparticle).

Herd immunity arises when enough of the population is immune that an infected person infects on average <1 new susceptible — the chain of transmission breaks. Threshold = 1 − 1/R₀.

Worked example. Calculate the herd-immunity threshold for measles (R₀ ≈ 15) and explain why outbreaks recur in vaccine-hesitant communities. Threshold = 1 − 1/15 ≈ 93%. If vaccine uptake falls below this in a sufficiently large local population, measles can re-establish endemic transmission. This is exactly what has happened in some communities in Europe and North America since the late 1990s anti-vaccine movement.

A common pitfall is to think vaccines cause the disease (only live-attenuated vaccines pose any risk, and only in severely immunocompromised individuals). Another is to confuse active immunity (recipient's own antibody production, durable) with passive immunity (pre-formed antibodies, short-lived, no memory — e.g. maternal IgG via placenta).

See the vaccination lesson for vaccine-type comparison and herd-immunity threshold diagrams.

Antibiotics and Antimicrobial Resistance

Antibiotics target bacterial-specific structures or processes for selective toxicity. Major classes: β-lactams (penicillins, cephalosporins — bind transpeptidase, inhibit peptidoglycan crosslinking → osmotic lysis); aminoglycosides (streptomycin, gentamicin — bind 70S ribosome, mistranslation); tetracyclines, macrolides (bacteriostatic 70S inhibitors); fluoroquinolones (DNA gyrase inhibitors); sulfonamides (folate-synthesis blockers).

Antimicrobial resistance (AMR) mechanisms: enzymatic degradation (β-lactamases, including extended-spectrum ESBL); target modification (altered PBPs in MRSA — penicillin-binding protein 2a has reduced β-lactam affinity); efflux pumps (active export of drug from cell); reduced permeability (altered porins); biofilm tolerance (bacteria in biofilms survive antibiotic exposure via reduced metabolism, drug-penetration barriers, persister cells).

Resistance spreads by horizontal gene transfer — much faster than mutation alone. Three routes: conjugation (sex pili form a bridge → plasmid transferred); transformation (uptake of free DNA from environment); transduction (bacteriophage-mediated transfer). Plasmid-borne resistance genes can carry resistance to multiple antibiotic classes simultaneously, spreading between bacterial species in hours under selective pressure.

The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) are the WHO-priority hospital-acquired multidrug-resistant strains.

Worked example. Predict the consequence of widespread agricultural antibiotic use on human medicine. Subtherapeutic antibiotic doses in livestock create chronic selective pressure, favouring resistant bacterial strains. These can cross to humans via the food chain, direct contact, or environmental contamination. Resistance plasmids can transfer from agricultural strains to human-pathogen strains via horizontal gene transfer. The result is broad erosion of antibiotic effectiveness, contributing to the global AMR crisis. WHO and EU policy now restrict antibiotic use in agriculture, particularly drugs of last resort like colistin.

A common pitfall is to confuse bacteriostatic (inhibits growth) with bactericidal (kills directly). Another is to think AMR arises only via mutation — horizontal gene transfer is much faster.

See the antibiotics and AMR lesson for mechanism and resistance-strategy diagrams.

Common Mark-Loss Patterns

• Calling all microorganisms "bacteria" generically — distinguish bacteria, viruses, fungi, and protoctista by structure.
• Confusing the 70S/80S ribosome distinction.
• Forgetting controls in aseptic technique (sterile-medium and no-inoculum plates).
• Confusing viable count and total count.
• Thinking all viruses are lytic.
• Confusing pathogen with disease, or vector with reservoir.
• Saying plants don't have an immune system.
• Treating non-specific immunity as unsophisticated (PRRs are evolved and specific to pathogen classes).
• Confusing CD4⁺ T-helper (MHC II, cytokines) with CD8⁺ cytotoxic (MHC I, killer).
• Missing the two-signal rule for T-cell activation.
• Thinking antibodies kill bacteria directly (mostly opsonisation, complement, agglutination, neutralisation).
• Confusing primary and secondary response curves.
• Thinking AMR arises only by mutation (horizontal gene transfer is faster).
• Confusing bacteriostatic with bactericidal.

How to Revise This Topic

• Build a pathogen-class comparison table for bacteria, viruses, fungi, protoctista — structure, replication, examples, antibiotic class.
• Master the phagocytosis cascade (PAMP → PRR → cytokines → chemotaxis → opsonisation → engulfment → phagolysosome → antigen presentation) until it's automatic.
• Drill the adaptive-immunity activation pathway (APC → MHC II → CD4⁺ → cytokines → B cells → plasma + memory).
• Memorise the five immunoglobulin classes with one structural and one functional fact each.
• Practice herd-immunity calculations for diseases of varying R₀.
• For AMR questions, structure your answer in three stages: target → mechanism of action → resistance mechanism.
• Use the LearningBro Examiner Mode to drill 6-mark and 9-mark questions on each system.

Linking to Other Topics

Immunity, Infection and Forensics is heavily synoptic. Cells, viruses and reproduction provides the prokaryotic-vs-eukaryotic structural distinction (and the 70S/80S ribosome story) underpinning selective antibiotic toxicity. Biological molecules supplies the antibody quaternary structure, peptidoglycan chemistry, and the molecular targets for antibiotics. Modern genetics builds on V(D)J recombination as the source of adaptive-immunity diversity. The control systems cytokine signalling logic underlies inflammation. And vaccination intersects with exchange and transport when discussing herd immunity in respiratory diseases.

Final Word

Immunity, Infection and Forensics is one of the most generous topics on 9BI0 — clinical relevance is overwhelming, the mechanisms are mature, and the questions are predictable. Drill the pathogen classes, master one immune cascade in detail (phagocytosis or B-cell activation), learn herd-immunity arithmetic, and practice extended-response questions on AMR until the language flows automatically. The full LearningBro Immunity, Infection and Forensics course walks through every sub-topic with diagrams, worked examples, AI tutor feedback, and Examiner Mode marking. Get this section right and the immunological vocabulary you build here will support both Paper 1 and many synoptic Paper 3 questions.